Beyond What Exists - Discovering What’s Possible

Our products focus on current & emerging needs

Better Input. Better Outcomes.

Insight. Effort. Results. These three words summarize Endo Pharmaceuticals. We listen to patients and doctors. We build on what we learn. And we collaborate with our partners to create innovative drugs and delivery systems. Solutions that inspire the medical, economic and practical outcomes we all want. It's this unique combination of forces that drives Endo Pharmaceuticals beyond what exists—to discover what's possible.

Investor Information

ENDP (Common Stock)

NASDAQ

Price

$84.40

Change

0.69 (0.82%)

Auxilium Pharmaceuticals

Endo recently completed the acquisition of Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company.

Therapeutic Areas

Pain Management

We believe pain management should be more than a goal. That's why we made it one of our specialties.

Learn More

Urology

We focus on many urological medical problems people are facing today: Low testosterone, erectile dysfunction, Peyronie's disease, bladder cancer and prostate cancer.

Learn More

Endocrinology

We're dedicated to meeting the needs of children and families affected by central precocious puberty (CPP).

Learn More

Orthopedic

We provide a solution for patients diagnosed with Dupuytren's contracture where a cord can be felt.

Learn More

Career Opportunities

MA HCP Opt-Out Request Form

Massachusetts prescribers may opt-out of future Endo Pharmaceuticals communications by completing the MA HCP Opt-Out Request Form.

About Endo

Close

Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, PA.

Visit Endo.com